Company Filing History:
Years Active: 2017-2024
Title: Innovations in Nasal Drug Delivery: The Contributions of Joel Relethford
Introduction
Joel Relethford, an accomplished inventor based in Everett, WA, has made significant strides in the field of drug delivery systems. With a total of seven patents to his name, Relethford focuses primarily on innovations that enhance the efficiency of nasal drug delivery mechanisms. His work has crucial implications for the medical field, especially in targeting the brain directly via the olfactory region.
Latest Patents
Two of Joel Relethford’s latest patents showcase his advanced engineering solutions in nasal drug delivery. The first patent involves a specialized nozzle designed for nasal drug delivery. This innovative nozzle is structured to receive a mixture of aerosolized propellant and drug formulation. It features a drug product inlet located at the proximal end, with multiple channels and orifice apertures facilitating effective delivery at the distal end.
The second patent introduces a compound delivery device that creates a plume from a propellant and a drug formulation. This device is significant because it allows the intranasal dosage form, whether in powder, suspension, dispersion, or liquid, to be delivered directly to the olfactory region, effectively bypassing the blood-brain barrier. The device employs hydrofluoroalkane propellant channeled from a pressurized canister, which aerosolizes the drug formulation for optimal delivery.
Career Highlights
Throughout his career, Joel has worked with esteemed companies, notably Impel Neuropharma, Inc. and Impel Pharmaceuticals Inc. His contributions to these organizations have been pivotal in advancing inhalation therapies that significantly improve patient outcomes. The combination of his practical experience and innovative thinking has positioned him as a leader in the development of modern drug delivery systems.
Collaborations
Joel Relethford has had the privilege of collaborating with prominent individuals in his field. Some of his notable coworkers include John D. Hoekman and Michael Hite. Their joint efforts have further propelled advancements in drug formulation and delivery systems, enhancing the efficacy of treatments available in the market today.
Conclusion
With seven patents under his belt, Joel Relethford stands out as a visionary inventor in the realm of nasal drug delivery. His pioneering work not only contributes to the scientific community but also positively impacts patient care by facilitating more effective delivery of treatments to the brain. As innovations in drug delivery continue to evolve, Relethford's contributions will undoubtedly remain influential.